Aims & Scope

Current Pharmacology Reports will: publish cutting-edge reviews on subjects pertinent to all aspects of pharmacology, including drug discovery and development, provide incisive, insightful, and balanced contributions from international leading experts, interest a wide readership of basic scientists and translational investigators in academia and in industry.

The Current Pharmacology Reports journal accomplishes its goal by appointing international authorities to serve as Section Editors in key subject areas, such as: epigenetics and epigenomics, chemoinformatics and rational drug design and target discovery, drug delivery and biomaterial, pharmacogenomics and molecular targets and biomarkers, chemical/drug/molecular toxicology, absorption, distribution, metabolism and elimination (ADME), pharmacokinetics (PK) and pharmacodynamics (PD), Modeling & Simulation (M&S) and pharmacometrics, and other related topics in pharmacology including neurology/central nervous system (CNS), cardiovascular, metabolic diseases, cancer, among others.

Section Editors for Current Pharmacology Reports select topics for which leading experts contribute comprehensive review articles that emphasize new developments and recently published papers of major importance, highlighted by annotated reference lists.

An Editorial Board of internationally diverse members suggests topics of special interest to their country/region and ensures that topics are current and include emerging research.

Commentaries from well-known figures in the field are also provided.

This journal publishes on a bi-monthly schedule.

View Aims & Scope

Metrics & Ranking

SJR (SCImago Journal Rank)

Year Value
2024 0.441

Quartile

Year Value
2024 Q3

h-index

Year Value
2024 39

Journal Rank

Year Value
2024 12836

Journal Citation Indicator

Year Value
2024 259

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.


Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Biochemistry, Genetics and Molecular Biology and Pharmacology, Toxicology and Pharmaceutics, designed to support cutting-edge academic discovery.


SJR (SCImago Journal Rank)

SJR
0.441
First Published: 2024

Quartile

Current Quartile
Q3
First Published: 2024

Similar Journals

Top Journals in Related Fields